FOR THE NEXT GENERATION OF PHYSICIANS
← All USMLE guides
PSYCHIATRY AND BEHAVIORAL SCIENCE

Bipolar disorder: mania, lithium and mood stabilizers.

Bipolar I vs II, manic episode criteria, lithium toxicity and monitoring, valproate, lamotrigine and antipsychotic options.

Bipolar I is defined by a manic episode lasting at least a week. Bipolar II has hypomania and depression.

Diagnosis

Mania: elevated or irritable mood, decreased need for sleep, grandiosity, pressured speech, distractibility and risk-taking (DIG FAST). Psychosis can occur. Hypomania lasts at least four days and does not impair function.

Lithium

First-line mood stabilizer. Narrow therapeutic index. Adverse effects: tremor, hypothyroidism, nephrogenic diabetes insipidus, Ebstein anomaly in pregnancy and weight gain. Toxicity is raised by dehydration, thiazides, ACE inhibitors and NSAIDs. Monitor levels, renal and thyroid function.

Alternatives

Valproate and carbamazepine for acute mania, lamotrigine for bipolar depression maintenance (rash risk), and second-generation antipsychotics (olanzapine, quetiapine). Avoid antidepressant monotherapy in bipolar disorder because it can induce mania.

Keep going in psychiatry and behavioral science

Related on USMLE WEB

Frequently asked questions

Which lithium effect involves the kidney?

Nephrogenic diabetes insipidus.

Which cardiac defect follows first-trimester lithium?

Ebstein anomaly.